[Edaily Reporter Shin Ha-yeon ] YMC Co., Ltd.(155650), a company specializing in semiconductor and display materials and components, announced on the 30th that executives, including CEO Lee Yoon-yong, had purchased a total of 34,000 shares on the open market.
According to YMC Co., Ltd., CEO Lee purchased a total of 30,000 shares on the open market in two separate transactions. Chief Financial Officer (CFO) Park Jeong-geun also purchased a total of 4,000 shares on the open market. As a result, CEO Lee, the company’s largest shareholder, saw his stake rise by 1.02 percentage points to 33.51%. A company official explained, “This share purchase demonstrates management’s confidence in the company’s future growth potential and the possibility of enhancing corporate value,” adding, “Even amid increasing internal and external volatility, the growth potential of our new semiconductor business is strengthening, so we will spare no effort to achieve mutual growth with the market through responsible management.”
YMC Co., Ltd. operates in the semiconductor and display materials and components sectors. The company forecasts that demand for silicon carbide (SiC) recycling will continue to rise this year due to an increase in etching processes driven by expanding semiconductor demand. The company plans to strengthen the competitiveness of its semiconductor components and solidify the foundation for growth at the group level.
Results from its new semiconductor business are also becoming visible. Building on its manufacturing capabilities for SiC rings—its existing flagship product—YMC Co., Ltd. received a purchase order (PO) in May from a U.S.-based semiconductor equipment manufacturer for three new types of semiconductor components, including edge rings. These products have passed final quality verification, and the initial shipment has been completed.
The company explained that this delivery is significant because it marks its entry into the official supply chain of a global semiconductor equipment manufacturer, moving beyond the domestic component market. In particular, since it simultaneously supplied three new components requiring highly sophisticated process technology, the company is credited with having earned recognition for its precision machining capabilities and quality reliability.
YMC Co., Ltd. stated, “This delivery of new products to a major U.S. equipment manufacturer is a crucial milestone in expanding our semiconductor revenue share and a signal of our global expansion,” adding, “Based on our proven core component manufacturing capabilities, we will continue to expand our high-value-added product lineup to accelerate the acquisition of global clients.”
Meanwhile, through its corporate value enhancement plan announced last April, YMC Co., Ltd. set forth key objectives: establishing a stable management foundation; expanding new revenue streams; securing mid- to long-term growth engines through investment in new businesses and technologies; and strengthening structural competitiveness to better respond to market changes.
To this end, the company plans to pursue cost reductions and production efficiency improvements, identify new high-value-added revenue streams, and invest in core technologies to continuously enhance shareholder value. Additionally, the company announced that it qualifies as a high-dividend company under the Act on the Limitation of Special Tax Treatments, with a dividend payout ratio of 100.52% and a dividend payout amount of 1.32849 billion won for 2025.
ABLE C&C(078520)is establishing a subsidiary in the Netherlands to serve as the control tower for its European operations. Following the establishment of its UK subsidiary, the company is setting up a…
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…